Literature DB >> 21807047

Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function.

Oludare Odumosu1, Dequina Nicholas, Kimberly Payne, William Langridge.   

Abstract

Dendritic cells are the largest population of antigen presenting cells in the body. One of their main functions is to regulate the delicate balance between immunity and tolerance responsible for maintenance of immunological homeostasis. Disruption of this delicate balance often results in chronic inflammation responsible for initiation of organ specific autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and type I diabetes. The cholera toxin B subunit (CTB) is a weak mucosal adjuvant known for its ability to stimulate immunity to antigenic proteins. However, conjugation of CTB to many autoantigens can induce immunological tolerance resulting in suppression of autoimmunity. In this study, we examined whether linkage of CTB to a 5kDa C-terminal protein fragment of the major diabetes autoantigen glutamic acid decarboxylase (GAD(35)), can block dendritic cell (DC) functions such as biosynthesis of co-stimulatory factor proteins CD86, CD83, CD80 and CD40 and secretion of inflammatory cytokines. The results of human umbilical cord blood monocyte-derived DC-GAD(35) autoantigen incubation experiments showed that inoculation of immature DCs (iDCs), with CTB-GAD(35) protein dramatically suppressed levels of CD86, CD83, CD80 and CD40 co-stimulatory factor protein biosynthesis in comparison with GAD(35) alone inoculated iDCs. Surprisingly, incubation of iDCs in the presence of the CTB-autoantigen and the strong immunostimulatory molecules PMA and Ionomycin revealed that CTB-GAD(35) was capable of arresting PMA+Ionomycin induced DC maturation. Consistent with this finding, CTB-GAD(35) mediated suppression of DC maturation was accompanied by a dramatic decrease in the secretion of the pro-inflammatory cytokines IL-12/23p40 and IL-6 and a significant increase in secretion of the immunosuppressive cytokine IL-10. Taken together, our experimental data suggest that linkage of the weak adjuvant CTB to the dominant type 1 diabetes autoantigen GAD strongly inhibits DC maturation through the down regulation of major co-stimulatory factors and inflammatory cytokine biosynthesis. These results emphasize the possibility that CTB-autoantigen fusion proteins enhance DC priming of naïve Th0 cell development in the direction of immunosuppressive T lymphocytes. The immunological phenomena observed here establish a basis for improvement of adjuvant augmented multi-component subunit vaccine strategies capable of complete suppression of organ-specific autoimmune diseases in vivo.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807047      PMCID: PMC3551541          DOI: 10.1016/j.vaccine.2011.07.077

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  58 in total

1.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.

Authors:  Zhaohui Gong; Yongfeng Jin; Yaozhou Zhang
Journal:  Vaccine       Date:  2006-11-03       Impact factor: 3.641

3.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

Authors:  Harald H Hofstetter; Saleh M Ibrahim; Dirk Koczan; Niels Kruse; Andreas Weishaupt; Klaus V Toyka; Ralf Gold
Journal:  Cell Immunol       Date:  2005-12-28       Impact factor: 4.868

4.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

5.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

6.  Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.

Authors:  Sridevi Devaraj; Nicole Glaser; Steve Griffen; Janice Wang-Polagruto; Eric Miguelino; Ishwarlal Jialal
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

7.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 8.  Autoimmune destruction of pancreatic beta cells.

Authors:  Ji-Won Yoon; Hee-Sook Jun
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

Review 9.  Targeting cytokines of the interleukin-12 family in autoimmunity.

Authors:  Bok Yun Kang; Tae Sung Kim
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

10.  Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation.

Authors:  Ting Li; Ji Zhong; Yingyu Chen; Xiaoyan Qiu; Ting Zhang; Dalong Ma; Wenling Han
Journal:  Life Sci       Date:  2006-03-07       Impact factor: 5.037

View more
  12 in total

Review 1.  Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Authors:  Yonghyun Lee; Nobuhiko Kamada; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2021-10-26       Impact factor: 15.470

Review 2.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

Review 3.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

4.  Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

Authors:  Kwang-Chul Kwon; Ramya Nityanandam; James S New; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2012-10-18       Impact factor: 9.803

Review 5.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 6.  The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity.

Authors:  Jacques C Mbongue; Dequina A Nicholas; Timothy W Torrez; Nan-Sun Kim; Anthony F Firek; William H R Langridge
Journal:  Vaccines (Basel)       Date:  2015-09-10

7.  Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.

Authors:  Jacques C Mbongue; Dequina A Nicholas; Kangling Zhang; Nan-Sun Kim; Brittany N Hamilton; Marco Larios; Guangyu Zhang; Kazuo Umezawa; Anthony F Firek; William H R Langridge
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

Review 8.  Cholera toxin B: one subunit with many pharmaceutical applications.

Authors:  Keegan J Baldauf; Joshua M Royal; Krystal Teasley Hamorsky; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2015-03-20       Impact factor: 4.546

Review 9.  Novel adjuvants & delivery vehicles for vaccines development: a road ahead.

Authors:  Teena Mohan; Priyanka Verma; D Nageswara Rao
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

Review 10.  The role of dendritic cells in tissue-specific autoimmunity.

Authors:  Jacques Mbongue; Dequina Nicholas; Anthony Firek; William Langridge
Journal:  J Immunol Res       Date:  2014-04-30       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.